HÖFFLIN, Rouven, LAZAROU, Adriana, HESS, Maria Elena, REISER, Meike, WEHRLE, Julius, METZGER, Patrick, FREY, Anna-Verena, BECKER, Heiko, AUMANN, Konrad, BERNER, Kai, BOEKER, Martin, BÜTTNER, Nico, DIERKS, Christine, DUQUE AFONSO, Jesús, EISENBLÄTTER, Michel, ERBES, Thalia, FRITSCH, Ralph, GE, Isabell Xiang, GEISSLER, Anna-Lena, GRABBERT, Markus Tobias, HEEG, Steffen, HEILAND, Dieter Henrik, HETTMER, Simone, KAYSER, Gian, KELLER, Alexander, KLEIBER, Anita, KUTILINA, Alexandra, MEHMED, Leman, MEISS, Frank, POXLEITNER, Philipp Johann, RAWLUK, Justyna, RUF, Juri, SCHÄFER, Henning Sebastian, SCHERER, Florian Paul, SHOUMARIYEH, Khalid, TZSCHACH, Andreas, PETERS, Christoph, BRUMMER, Tilman, WERNER, Martin, DUYSTER, Justus, LASSMANN, Silke, MIETHING, Cornelius, BÖRRIES, Melanie, ILLERT, Anna Lena und BUBNOFF, Nikolas von, 2021. Transitioning the molecular tumor board from proof of concept to clinical routine: a german single-center analysis. Freiburg: Universität.

Höfflin, R., Lazarou, A., Hess, M.E., Reiser, M., Wehrle, J., Metzger, P., Frey, A.-V., Becker, H., Aumann, K., Berner, K., Boeker, M., Büttner, N., Dierks, C., Duque Afonso, J., Eisenblätter, M., Erbes, T., Fritsch, R., Ge, I.X., Geißler, A.-L., Grabbert, M.T., Heeg, S., Heiland, D.H., Hettmer, S., Kayser, G., Keller, A., Kleiber, A., Kutilina, A., Mehmed, L., Meiß, F., Poxleitner, P.J., Rawluk, J., Ruf, J., Schäfer, H.S., Scherer, F.P., Shoumariyeh, K., Tzschach, A., Peters, C., Brummer, T., Werner, M., Duyster, J., Laßmann, S., Miething, C., Börries, M., Illert, A.L., Bubnoff, N. von, 2021. Transitioning the molecular tumor board from proof of concept to clinical routine: a german single-center analysis. Universität, Freiburg. https://doi.org/10.3390/cancers13051151

Höfflin, R., Lazarou, A., Hess, M. E., Reiser, M., Wehrle, J., Metzger, P., Frey, A.-V., Becker, H., Aumann, K., Berner, K., Boeker, M., Büttner, N., Dierks, C., Duque Afonso, J., Eisenblätter, M., Erbes, T., Fritsch, R., Ge, I. X., Geißler, A.-L., Grabbert, M. T., Heeg, S., Heiland, D. H., Hettmer, S., Kayser, G., Keller, A., Kleiber, A., Kutilina, A., Mehmed, L., Meiß, F., Poxleitner, P. J., Rawluk, J., Ruf, J., Schäfer, H. S., Scherer, F. P., Shoumariyeh, K., Tzschach, A., Peters, C., Brummer, T., Werner, M., Duyster, J., Laßmann, S., Miething, C., Börries, M., Illert, A. L., & Bubnoff, N. von. (ca. 2021). Transitioning the molecular tumor board from proof of concept to clinical routine: a german single-center analysis [Cd]. Universität. https://doi.org/10.3390/cancers13051151

Höfflin R, Lazarou A, Hess ME, Reiser M, Wehrle J, Metzger P, Frey A-V, Becker H, Aumann K, Berner K, Boeker M, Büttner N, Dierks C, Duque Afonso J, Eisenblätter M, Erbes T, Fritsch R, Ge IX, Geißler A-L, Grabbert MT, Heeg S, Heiland DH, Hettmer S, Kayser G, Keller A, Kleiber A, Kutilina A, Mehmed L, Meiß F, Poxleitner PJ, Rawluk J, Ruf J, Schäfer HS, Scherer FP, Shoumariyeh K, Tzschach A, Peters C, Brummer T, Werner M, Duyster J, Laßmann S, Miething C, Börries M, Illert AL, Bubnoff N von (2021) Transitioning the molecular tumor board from proof of concept to clinical routine: a german single-center analysis. Universität, Freiburg

Höfflin, Rouven/ Lazarou, Adriana/ Hess, Maria Elena/ Reiser, Meike/ Wehrle, Julius/ Metzger, Patrick/ Frey, Anna-Verena/ Becker, Heiko/ Aumann, Konrad/ Berner, Kai/ Boeker, Martin/ Büttner, Nico/ Dierks, Christine/ Duque Afonso, Jesús/ Eisenblätter, Michel/ Erbes, Thalia/ Fritsch, Ralph/ Ge, Isabell Xiang/ Geißler, Anna-Lena/ Grabbert, Markus Tobias/ Heeg, Steffen/ Heiland, Dieter Henrik/ Hettmer, Simone/ Kayser, Gian/ Keller, Alexander/ Kleiber, Anita/ Kutilina, Alexandra/ Mehmed, Leman/ Meiß, Frank/ Poxleitner, Philipp Johann/ Rawluk, Justyna/ Ruf, Juri/ Schäfer, Henning Sebastian/ Scherer, Florian Paul/ Shoumariyeh, Khalid/ Tzschach, Andreas/ Peters, Christoph/ Brummer, Tilman/ Werner, Martin/ Duyster, Justus/ Laßmann, Silke/ Miething, Cornelius/ Börries, Melanie/ Illert, Anna Lena/ Bubnoff, Nikolas von, Transitioning the molecular tumor board from proof of concept to clinical routine: a german single-center analysis, Freiburg 2021.